An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
October 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
February 28, 2013
Conditions
Alzheimer's Disease
Interventions
DRUG
E2609
Trial Locations (1)
91206
California Clinical Trials/Parexel, Glendale
All Listed Sponsors
lead
Eisai Inc.
INDUSTRY
NCT01716897 - An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption | Biotech Hunter | Biotech Hunter